Tumor
Canonical Gene Amplifications and CDKN2A/B Loss Stratify Risk in IDH1/2-mutant Astrocytoma Patients
Hia Ghosh, Bachelor of Science
Research Data AnalystMass General BrighamBoston, Massachusetts, United States